HPV-039 study group. Efficacy, immunogenicity and safety of the HPV-16/18 AS04-adjuvanted vaccine in healthy Chinese women aged 18-25 years: results from a randomized controlled trial
点击次数：
发表刊物：Int J Cancer.
论文类型：基础研究
期号：2014 Dec 1;135(11):2612-22.
是否译文：否